Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


08.07.2024

1 Ann Neurol
2 BMC Neurol
3 Intern Med
1 J Autoimmun
1 J Immunol
2 J Neurol
4 J Rheumatol
3 Lancet
1 Nat Rev Neurol
2 Neurology
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. BRIER MR, Schindler SE, Salter A, Perantie D, et al
    Unexpected Low Rate of Amyloid-beta Pathology in Multiple Sclerosis Patients.
    Ann Neurol. 2024 Jul 4. doi: 10.1002/ana.27027.
    PubMed         Abstract available


    BMC Neurol

  2. ZHOU Y, Chen Q, Gan W, Lin X, et al
    Comparison between MRI-negative and positive results and the predictors for a poor prognosis in patients with idiopathic acute transverse myelitis.
    BMC Neurol. 2024;24:226.
    PubMed         Abstract available

  3. REINHARDT A, Rakers SE, Heersema DJ, Beenakker EAC, et al
    Protocol for the MS-CEBA study: an observational, prospective cohort study identifying Cognitive, Energetic, Behavioural and Affective (CEBA) profiles in Multiple Sclerosis to guide neuropsychological treatment choice.
    BMC Neurol. 2024;24:224.
    PubMed         Abstract available


    Intern Med

  4. YAMASHITA K, Miyazawa K, Murakami K, Nakashima I, et al
    Primary Angiitis of the Central Nervous System with Pathological Findings of Eosinophilic Granulomatosis with Polyangiitis.
    Intern Med. 2024;63:1939-1943.
    PubMed         Abstract available

  5. TAKAHASHI A, Ohira H, Abe K, Zeniya M, et al
    Autoimmune Hepatitis with Metabolic Dysfunction-associated Fatty Liver Disease.
    Intern Med. 2024 Jul 4. doi: 10.2169/internalmedicine.3112.
    PubMed         Abstract available

  6. YAMAMOTO A, Nishimori H, Shirai T, Takano K, et al
    Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome.
    Intern Med. 2024;63:1917-1922.
    PubMed         Abstract available


    J Autoimmun

  7. YUAN L, Wang Y, Shen X, Ma F, et al
    Soluble form of immune checkpoints in autoimmune diseases.
    J Autoimmun. 2024;147:103278.
    PubMed         Abstract available


    J Immunol

  8. PATINO-MARTINEZ E, Nakabo S, Jiang K, Carmona-Rivera C, et al
    The Aconitate Decarboxylase 1/Itaconate Pathway Modulates Immune Dysregulation and Associates with Cardiovascular Disease Markers and Disease Activity in Systemic Lupus Erythematosus.
    J Immunol. 2024 Jul 1:ji2400241. doi: 10.4049/jimmunol.2400241.
    PubMed         Abstract available


    J Neurol

  9. DELUCA J
    Fatigue in multiple sclerosis: can we measure it and can we treat it?
    J Neurol. 2024 Jul 5. doi: 10.1007/s00415-024-12524.
    PubMed         Abstract available

  10. ROT U, Jerala M, Horvat Ledinek A, Brecl Jakob G, et al
    Progressive multifocal leukoencephalopathy in association with siponimod treatment for secondary progressive multiple sclerosis: a case report.
    J Neurol. 2024 Jul 3. doi: 10.1007/s00415-024-12542.
    PubMed        


    J Rheumatol

  11. TELES MS, Brundage J, Chiang TP, Alejo JL, et al
    Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2024 Jul 1:jrheum.2023-1212. doi: 10.3899/jrheum.2023-1212.
    PubMed         Abstract available

  12. TANI C, Cardelli C, Zen M, Moroni L, et al
    Anifrolumab In Refractory Systemic Lupus Erythematosus: A Real-Life, Multicenter Study.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0053. doi: 10.3899/jrheum.2024-0053.
    PubMed         Abstract available

  13. BAGGETT KH, Brandon TG, Xiao R, Weiss PF, et al
    Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study.
    J Rheumatol. 2024;51:708-714.
    PubMed         Abstract available

  14. BOWDISH DME, Chandran V, Hitchon CA, Kaplan GG, et al
    When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
    J Rheumatol. 2024;51:721-727.
    PubMed         Abstract available


    Lancet

  15. LAFAYETTE R, Kristensen J, Stone A, Barratt J, et al
    Targeted release of budesonide in primary IgA nephropathy - Authors' reply.
    Lancet. 2024;403:2786.
    PubMed        

  16. ZOU Y, Du X, Zou J
    Targeted release of budesonide in primary IgA nephropathy.
    Lancet. 2024;403:2785-2786.
    PubMed        

  17. HU Y, Zhang Y
    Targeted release of budesonide in primary IgA nephropathy.
    Lancet. 2024;403:2785.
    PubMed        


    Nat Rev Neurol

  18. OH J, Bar-Or A
    Precision neuroimmunology in multiple sclerosis - the horizon is near.
    Nat Rev Neurol. 2024 Jul 4. doi: 10.1038/s41582-024-00992.
    PubMed        


    Neurology


  19. Characterization Profiles of ANCA-associated Vasculitis With Neurological Manifestations (P7-14.007).
    Neurology. 2024;103:e209640.
    PubMed        


  20. Artificial Intelligence-Based Ocular Motor Biomarkers for Myasthenia Gravis Diagnosis (P10-11.016).
    Neurology. 2024;103:e209639.
    PubMed        


    PLoS One

  21. HE L, He W
    Clinicopathologic features and outcomes of bilateral lacrimal gland lesions.
    PLoS One. 2024;19:e0305717.
    PubMed         Abstract available

  22. GEBREMESKEL GG, Haile TG, Gebrewahd GT, Hailay A, et al
    Effectiveness of non-pharmacological therapies for chronic pain in people with autoimmune diseases in Africa: A protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0306564.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  23. NATARAJAN C, Le LHD, Gunasekaran M, Tracey KJ, et al
    Electrical stimulation of the vagus nerve ameliorates inflammation and disease activity in a rat EAE model of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2024;121:e2322577121.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.